BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

939 related articles for article (PubMed ID: 7758941)

  • 1. Inhibitors of mammalian G1 cyclin-dependent kinases.
    Sherr CJ; Roberts JM
    Genes Dev; 1995 May; 9(10):1149-63. PubMed ID: 7758941
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressors and oncogenes in cellular senescence.
    Bringold F; Serrano M
    Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
    Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax.
    van Lookeren Campagne M; Gill R
    J Comp Neurol; 1998 Jul; 397(2):181-98. PubMed ID: 9658283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming inhibitions: subversion of CKI function by viral cyclins.
    Swanton C; Card GL; Mann D; McDonald N; Jones N
    Trends Biochem Sci; 1999 Mar; 24(3):116-20. PubMed ID: 10203759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
    Gray-Bablin J; Rao S; Keyomarsi K
    Cancer Res; 1997 Feb; 57(4):604-9. PubMed ID: 9044834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
    Grzelakowska-Sztabert B
    Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of cell cycle regulator genes in KB, a human squamous cell carcinoma cell line, after irradiation.
    Uno M; Otsuki T; Hiratsuka J; Yoden E; Aihara T; Harada T; Imajo Y
    Int J Oncol; 2000 Nov; 17(5):947-54. PubMed ID: 11029497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Chellappan SP; Giordano A; Fisher PB
    Curr Top Microbiol Immunol; 1998; 227():57-103. PubMed ID: 9479826
    [No Abstract]   [Full Text] [Related]  

  • 14. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
    J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK inhibitors: positive and negative regulators of G1-phase progression.
    Sherr CJ; Roberts JM
    Genes Dev; 1999 Jun; 13(12):1501-12. PubMed ID: 10385618
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27(Kip1).
    Groshong SD; Owen GI; Grimison B; Schauer IE; Todd MC; Langan TA; Sclafani RA; Lange CA; Horwitz KB
    Mol Endocrinol; 1997 Oct; 11(11):1593-607. PubMed ID: 9328342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting CDK inhibitors: new lessons from DNA tumor viruses.
    Funk JO; Galloway DA
    Trends Biochem Sci; 1998 Sep; 23(9):337-41. PubMed ID: 9787639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.